Race and the natural history of chronic heart failure: A propensity-matched study

被引:15
作者
Gambassi, Giovanni [2 ]
Agha, Syed Abbas [3 ]
Sui, Xuemei [4 ]
Yancy, Clyde W. [5 ]
Butler, Javed [3 ]
Giamouzis, Grigorios [3 ,6 ]
Love, Thomas E. [7 ]
Ahmed, Ali [1 ,8 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Univ S Carolina, Columbia, SC 29208 USA
[5] Baylor Univ, Med Ctr, Dallas, TX USA
[6] Onassis Cardiac Surg Ctr, Athens, Greece
[7] Case Western Reserve Univ, Cleveland, OH 44106 USA
[8] VA Med Ctr, Birmingham, AL USA
关键词
heart failure; race; natural history; propensity scores;
D O I
10.1016/j.cardfail.2008.02.004
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Racial differences in the epidemiology and outcomes of heart failure are well known. However, the association of race with the natural history of heart failure has not been previously studied in a propensity-matched population of chronic heart failure in which all measured baseline patient characteristics are well-balanced between the races. Methods and Results: Of the 7788 patients with chronic systolic and diastolic heart failure in the Digitalis Investigation Group trial, 1128 were nonwhites. Propensity scores for being nonwhite were calculated for each patient and were used to match 10 18 pairs of white and nonwhite patients. Matched Cox regression analyses were used to estimate associations of race with outcomes during 38 months of median follow-up. All-cause mortality occurred in 34% (rate, 1180/10000 person-years) of whites and 33% (rate, 1130/10000 person-years) of nonwhite patients (hazard ratio when nonwhite patients were compared with whites, 0.95, 95% confidence interval, 0.80-1.14; P = .593). All-cause hospitalization occurred in 63% (rate, 3616/10000 person-years) of whites and 65% (rate, 3877/10000 person-years) of nonwhite patients (hazard ratio, 1.03, 95% confidence interval, 0.90-1.18; P = .701). Respective hazard ratios (95% confidence intervals) for other outcomes were: 0.95 (0.75-1.12) for cardiovascular mortality, 0.82 (0.60-1.11) for heart failure mortality, 1.05 (0.91-1.22) for cardiovascular hospitalization, and 1.17 (0.98-1.39) for heart failure hospitalization. Conclusions: In a propensity-matched population of heart failure patients where whites and nonwhites were balanced in all measured baseline characteristics, there were no racial differences in major natural history end points.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 33 条
[1]
Abernathy GT, 1996, CONTROL CLIN TRIALS, V17, P77
[2]
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure [J].
Ahmed, Ali ;
Zannad, Faiez ;
Love, Thomas E. ;
Tallaj, Jose ;
Gheorghiade, Mihai ;
Ekundayo, Olaniyi James ;
Pitt, Bertram .
EUROPEAN HEART JOURNAL, 2007, 28 (11) :1334-1343
[3]
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods [J].
Ahmed, Ali ;
Husain, Ahsan ;
Love, Thomas E. ;
Gambassi, Giovanni ;
Dell'Italia, Louis J. ;
Francis, Gary S. ;
Gheorghiade, Mihai ;
Allman, Richard M. ;
Meleth, Sreelatha ;
Bourge, Robert C. .
EUROPEAN HEART JOURNAL, 2006, 27 (12) :1431-1439
[5]
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: A propensity matched study [J].
Ahmed, Ali ;
Rich, Michael W. ;
Sanders, Paul W. ;
Perry, Gilbert J. ;
Bakris, George L. ;
Zile, Michael R. ;
Love, Thomas E. ;
Aban, Inmaculada B. ;
Shlipak, Michael G. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03) :393-398
[6]
BiDil for heart failure in black patients: Implications of the U.S. Food and Drug Administration approval [J].
Bibbins-Domingo, Kirsten ;
Fernandez, Alicia .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (01) :52-W8
[7]
Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000 [J].
Brown, DW ;
Haldeman, GA ;
Croft, JB ;
Giles, WH ;
Mensah, GA .
AMERICAN HEART JOURNAL, 2005, 150 (03) :448-454
[8]
Determination of vital status at the end of the DIG trial [J].
Collins, JF ;
Howell, CL ;
Horney, A .
CONTROLLED CLINICAL TRIALS, 2003, 24 (06) :726-730
[9]
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[10]
2-B